International Journal of Advanced and Integrated Medical Sciences

Register      Login

VOLUME 2 , ISSUE 4 ( 2017 ) > List of Articles

REVIEW ARTICLE

Health and Social Problems of Geriatric Age Group

Hari S Joshi, Swati Khan, Deepak Upadhyay, Rakshita Ojha, Gaffar,  

Keywords : Elderly, Geriatric, Health issues, Health policy

Citation Information : Joshi HS, Khan S, Upadhyay D, Ojha R, G. Health and Social Problems of Geriatric Age Group. Int J Adv Integ Med Sci 2017; 2 (4):205-207.

DOI: 10.5005/jp-journals-10050-10108

License: CC BY-SA 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

There is a rapid increase in the geriatric population. In our nation, more than 5% of males and 4 to 5% of females belong to geriatric group. Although the proportion of elderly people in our nation compared with developing countries is on the lower side, the absolute number is on the higher side as compared with the developed world. Growing is a natural process for every being, hence geriatric stage cannot be prevented. However, a handful of things can be done by the family members of the elderly in helping them to lead a normal life, which is their uttermost necessity to perform their daily routine activities with ease. The commonest problem the elderly face is joint pain and diminished mobility. All the aspects of health status, lifestyle, life satisfaction, mental state, or well-being together reflect the multidimensional aspect of lifestyle of an individual. Mental health problems with the geriatric age people remain neglected most of the time. There is a different presentation of tuberculosis in older people as compared with that observed in young adult patients. There should be a separate classification of tuberculosis treatment for elderly people. Hence, diagnosis has to be made at the earliest and treatment not delayed, which, in the current scenario has led to a rise in morbidity and mortality in the geriatric group. How to cite this article Gaffar, Khan S, Joshi HS, Ojha R, Upadhyay D. Health and Social Problems of Geriatric Age Group. Int J Adv Integ Med Sci 2017;2(4):205-207.


PDF Share
  1. Sharma MK, Swami HM, Bhatia V, Verma A, Bhatia SP, Kaur G. An epidemiological study of correlates of osteo-arthritis in geriatric population of UT Chandigarh. Indian J Community Med 2007 Jan;32(1):77-78.
  2. Barua A, Mangesh R, Harsha Kumar HN, Mathew S. A cross-sectional study on quality of life in geriatric population. Indian J Community Med 2007 Apr;32(2):146-147.
  3. Pardeshi G, Deshmukh D. Disease characteristics and treatment outcome in elderly tuberculosis patients on DOTS. Indian J Community Med 2007 Oct;32(4):292-294.
  4. Marsden E, Taylor A, Wallis M, Craswell A, Broadbent M, Barnett A, Nguyen KH, Crilly J, Johnston C, Glenwright A. A structure, process and outcome evaluation of the Geriatric Emergency Department Intervention model of care: a study protocol. BMC Geriatr 2017 Mar;17:76.
  5. Gupta AA, Lall AK, Das A, Saurav A, Nandan A, Shah D, Agrahari A, Yadav DK. Health and socioeconomic status of the elderly people living in hilly areas of Pakhribas, Kosi Zone, Nepal. Indian J Community Med 2016 Oct-Dec;41(4):273-279.
  6. Parsons M. Cytokine strom in Pediatric oncology patient. J Pediatr Oncol Nurs 2010 Sep-Oct;27(5):253-258.
  7. Harianto H, Watson B, van der Klift J, Valentine S, Marriott J. The impact of the presence of systemic inflammatory response syndrome in the emergency department on the timing and outcomes of medical emergency team calls after admission: a retrospective audit. J Clin Gerontol Geriatr 2016 Dec;7(4):119-123.
  8. Pendyala G, Joshi S, Choudhary S. The ageing nation. Indian J Community Med 2014 Jan-Mar;39(1):3-7.
  9. Kiel S, Zimak C, Chenot JF, Schmidt CO. Evaluation of Ambulatory Geriatric Rehabilitation (EAGER): study protocol of a matched cohort study based on claims data. BMC Geriatr 2017 Mar;17:63.
  10. Owens D, Kalra S, Sahay R. Geriatric endocrinology. Indian J Endocrinol Metab 2011 Apr-Jun;15(2):71-72.
  11. Sherin Susan Paul N, Asirvatham M. Geriatric health policy in India: the need for scaling-up Implementation. J Family Med Prim Care 2016 Apr-Jun;5(2):242-247.
  12. Chambellan, M. Etude Anatomique et Anthropologique sur les Os Wormiens. Thesis, Paris. [Cited by Dorsey, 1897]. 1883.
  13. Russel F, Studies in Cranial Variation, Am Nat 1900;34:737-747.
  14. Wood-Jones F. The non-metrical morphological characters of the skull as criteria for racial diagnosis. IV. J Anat 1933-1934 Oct;68(Pt 1):96-108.
  15. Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) 2001 Apr;54(4):447-453.
  16. Karabulut AB, Cakmak M, Kiran RT, Sahin I. Oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome. Med Sci 2012 Jan;1(1):27-34.
  17. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003 Dec;254(6):555-563.
  18. Chan DC, Watts GF. LDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study? Eur J Clin Invest 2004 Nov;34(11):719-722.
  19. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos P. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007 Sep;18(7):280-285.
  20. Brunzell JD, Davidson M, Furberg CD. Lipoprotein management in patients with cardio metabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008 Apr;51(4):1512-1524.
  21. Nordestgaard BG, Langsted A, Freiberg JJ. Nonfasting hyperlipidemia and cardiovascular disease. Curr Drug Targets 2009 Apr;10(4):54-61.
  22. Peters AL. Clinical relevance of non-HDL cholesterol in patients with diabetes. Clin Diabetes 2008 Jan;26(1):3-7.
  23. Vaughan N, James K, McDermott D, Griest S, Fausti S. A 5-year prospective study of diabetes and hearing loss in a veteran population. Otol Neurotol 2006 Jan;27(1):37-43.
  24. Tosi A, Misciali C, Piraccini B, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 1994 Apr;10(4):310-317.
  25. Bronner AK, Hood AF. Cutaneous complication of chemotherapeutic agents. J Am Acad Dermatol 1983 Nov;9(5):645-663.
  26. Hood AF. Cutaneous side effects of cancer chemotherapy. Med Clin North Am 1986 Jan;70(1):187-209.
  27. Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncol Nurs Forum 1995 Jan-Feb;22(1):57-67.
  28. Malkinson, FD. Radiobiology of the skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th edn. New York: McGraw-Hill; 1999. pp. 1514-1523.
  29. Goldschmidt H, Breneman JC, Bareneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol 1994 Feb;30(2 Pt 1):157-182.
  30. Narkiewicz K, van de Borne P, Montano N, Hering D, Kara T, Somers VK. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension 2006;47(1):51-55.
  31. Agte VV, Chiplonkar SA. Sudarshan kriya yoga for improving antioxidant status and reducing anxiety in adults. Altern Complement Ther 2008;14(2):96-100.
  32. Jacobs GD. Clinical applications of the relaxation response and mind-body interventions. J Altern Complement Med 2001;7(Suppl 1):S93-S101.
  33. Singh N, Telles S. Heart rate variability and state anxiety in hypertensives and diabetes after one week of yoga. J Indian Psychol 2009;27(1-2):13-20.
  34. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV. J Hum Hypertens 2004 Mar;18(3):139-185.
  35. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011 Jul-Aug;27(4):415-433.e1-2.
  36. Wahlgren NG, MacMahon DG, De Keyser JF, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994 May;4(3):204-10.
  37. Kaste M, Fogelholm R, Erilä T, Palomäki H, Murros K, Rissanen A, Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994 Jul;25(7):1348-1353.
  38. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003 Jul;34(7):1699-1703.
  39. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011 Feb;377(9767):741-750.
  40. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009 Jan;8(1):48-56.
  41. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010 Aug;9(8):767-775.
  42. Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke 2013 Mar;44(3):870-947.
  43. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Stroke 2009 Jul;40(7):2442-2449.
  44. Karachalios GN, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK, Charalabopoulos K. Withdrawal syndrome following cessation of antihypertensive drug therapy. Int J Clin Pract 2005 May;59(5):562-570.
  45. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001 Sep;358(9287):1033-1041.
  46. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Stroke 2005 Jun;36(6):1218-1226.
  47. Yusuf S, Diener HC, Sacco RL, Cotton D, Ôunpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008 Sep;359(12):1225-1237.
  48. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2014 Jan:45(7):2160-2236.
  49. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009 Jun;53(6):952-958.
  50. Avni B, Frenkel G, Shahar L, Golik A, Sherman D, Dishy V. Aortic stiffness in normal and hypertensive pregnancy. Blood Press 2010 Feb;19(1):11-15.
  51. Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol 2012 Jul;40(1):28-34.
  52. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992 Feb;304(6824):405-412.
  53. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 Mar;359(9311):995-1003.
  54. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trials-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 Sep;366(9489):895-906.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.